Seegene Inc. partners with Springer Nature to award innovative research grants focused on pioneering diagnostic solutions for infectious diseases, reinforcing the global commitment towards a disease-free future.

Minesto AB, renowned for its innovative marine energy solutions, has officially registered its Rights Issue Prospectus with the Swedish authorities. This move signals a substantial step forward in bolstering green energy investments and aligning with global carbon footprint reduction goals.

Gear up for the launch of 'Mellow', the groundbreaking Mars-themed metaverse set to unveil its early access with surging token influx, redefining the entertainment and gaming industry.

A recent breakthrough in lithium-sulfur (Li-S) battery technology promises to transform the energy storage landscape, offering a significant leap in battery life, efficiency, and sustainability. With potential applications ranging from electric vehicles to renewable energy systems, this advancement is poised to redefine how we manage and utilize power in an eco-conscious era.

ACES India partners with UPMRCL to transform urban metro connectivity with state-of-the-art digital infrastructure, promising to enhance passenger experiences across the Agra and Kanpur corridors. This collaboration heralds a new era of digital sustainability and neutrality in services.

Bitmagic has launched an innovative 3D game-creation platform on Steam Early Access, enabling anyone to design games using simple text prompts. This transformative technology offers ease of access and the ability to create animated 3D objects, democratizing game production for creators of all skill levels.

CCELL® revolutionizes the European cannabis market by showcasing its latest vaporization technologies at Spannabis, Europe's premier cannabis fair.

Market research firm Technavio's recent insights indicate a substantial growth in the global robotics market, projecting a rise by USD 22.27 billion from 2022 to 2027 with a CAGR of 7.71%, driven by initiatives like Horizon 2020 and SME integration of robotics technology.

Selvita S.A. announces a significant strategic expansion into therapeutic antibody discovery, showcasing an ambitious move to enhance their biologic drug discovery and development capabilities. The initiative, indicative of Selvita's commitment to innovation, positions the company as a leader in biologic research and caters to the growing needs of the pharmaceutical industry.

Discover the explosive rise of Digital Surgery Technologies, set to hit $6.07 Bn by 2031, revolutionizing surgical precision and efficiency across the globe.